Cargando…
Higher Medication Adherence and Lower Opioid Use Among Individuals with Autoimmune Disease Enrolled in an Adalimumab Patient Support Program in the United States
INTRODUCTION: Opioid use is prevalent among patients with autoimmune conditions, despite not being a recommended treatment. Tumor necrosis factor inhibitor (anti-TNF) therapy is an effective treatment for these autoimmune conditions, and patient support programs (PSPs) have been developed to help pa...
Autores principales: | Fendrick, A. Mark, Macaulay, Dendy, Goldschmidt, Debbie, Liu, Harry, Brixner, Diana, Ali, Tauseef, Mittal, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217395/ https://www.ncbi.nlm.nih.gov/pubmed/33899166 http://dx.doi.org/10.1007/s40744-021-00309-9 |
Ejemplares similares
-
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population
por: Brixner, Diana, et al.
Publicado: (2019) -
Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit
por: Fendrick, A Mark, et al.
Publicado: (2021) -
Using Adalimumab to Treat Autoimmune Enteropathy
por: Trivedi, Hirsh D., et al.
Publicado: (2019) -
Impact of Medication Adherence on Healthcare Resource Utilization, Work Loss, and Associated Costs in a Privately Insured Employed Population Treated With Adalimumab in the United States
por: Mittal, Manish, et al.
Publicado: (2021) -
Impact of Online Prescription Management Systems on Biologic Treatment Initiation
por: Hawkes, Jason E., et al.
Publicado: (2019)